108 related articles for article (PubMed ID: 9316336)
1. Medical management of coronary artery disease revisited: the endothelial factor.
Siegel JA
J S C Med Assoc; 1997 Sep; 93(9):333-5. PubMed ID: 9316336
[TBL] [Abstract][Full Text] [Related]
2. [Statins--attaining goal values--with reference to recent studies].
Toplak H; Schallmoser K; DeCampo A
Wien Med Wochenschr; 1999; 149(5-6):144-5. PubMed ID: 10408006
[TBL] [Abstract][Full Text] [Related]
3. Medical therapy versus revascularization: the atorvastatin versus revascularization treatment AVERT trial.
Waters DD
Can J Cardiol; 2000 Jan; 16 Suppl A():11A-3A. PubMed ID: 10653925
[TBL] [Abstract][Full Text] [Related]
4. [Prevention and therapy of vascular damage and endothelial dysfunction with hypocholesteremic agents].
De Caterina R; Lenzi S
G Ital Cardiol; 1998 Feb; 28(2):168-77. PubMed ID: 9534058
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of cholesterol-lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol level using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Chikamori T; Sugimoto K; Hamada T; Kitaoka H; Furuno T; Seo H; Doi Y
J Cardiol; 2000 Feb; 35(2):95-101. PubMed ID: 10713930
[TBL] [Abstract][Full Text] [Related]
6. Economic benefits of aggressive lipid lowering: a managed care perspective.
McKenney JM; Kinosian B
Am J Manag Care; 1998 Jan; 4(1):65-74. PubMed ID: 10179907
[TBL] [Abstract][Full Text] [Related]
7. Statins in the prevention of coronary heart disease.
Williamson DR; Pharand C
Pharmacotherapy; 1998; 18(2):242-54. PubMed ID: 9545143
[TBL] [Abstract][Full Text] [Related]
8. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
9. [Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world].
Poli A; Menotti A
G Ital Cardiol; 1999 Oct; 29(10):1123-30. PubMed ID: 10546121
[No Abstract] [Full Text] [Related]
10. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
11. The benefit of cholesterol-lowering medications after coronary revascularization: a population study.
Brophy JM; Brassard P; Bourgault C
Am Heart J; 2005 Aug; 150(2):282-6. PubMed ID: 16086931
[TBL] [Abstract][Full Text] [Related]
12. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: Two-year follow-up of a new hybrid procedure compared with "on-pump" double bypass grafting.
de Cannière D; Jansens JL; Goldschmidt-Clermont P; Barvais L; Decroly P; Stoupel E
Am Heart J; 2001 Oct; 142(4):563-70. PubMed ID: 11579343
[TBL] [Abstract][Full Text] [Related]
13. [Statins have other beneficial properties besides their cholesterol lowering effect].
Eriksson M
Lakartidningen; 1998 Aug; 95(35):3670-2. PubMed ID: 9748780
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy.
Jaumdally R; Lip GY; Varma C
Int J Clin Pract; 2005 Sep; 59(9):1070-81. PubMed ID: 16115184
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy.
Fichtlscherer S; Schmidt-Lucke C; Bojunga S; Rössig L; Heeschen C; Dimmeler S; Zeiher AM
Eur Heart J; 2006 May; 27(10):1182-90. PubMed ID: 16621868
[TBL] [Abstract][Full Text] [Related]
16. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
17. Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease.
van der Harst P; Wagenaar LJ; Buikema H; Voors AA; Plokker HW; Morshuis WJ; Six AJ; Boonstra PW; Nickenig G; Wassmann S; van Veldhuisen DJ; van Gilst WH
Am J Cardiol; 2005 Nov; 96(10):1361-4. PubMed ID: 16275178
[TBL] [Abstract][Full Text] [Related]
18. [Anti-atherogenic drugs].
Kanaki T; Saito Y
Nihon Rinsho; 1998 Oct; 56(10):2635-9. PubMed ID: 9796331
[TBL] [Abstract][Full Text] [Related]
19. New concepts and paradigms in cardiovascular medicine: the noninvasive management of coronary artery disease.
Gould KL
Am J Med; 1998 Jun; 104(6A):2S-17S. PubMed ID: 9684847
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease.
Settergren M; Böhm F; Rydén L; Pernow J
Eur Heart J; 2008 Jul; 29(14):1753-60. PubMed ID: 18441323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
